Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Oligo Brain Metastases.

NCT04094077 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04094077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04094077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Oligo Brain Metastases.
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Terminated
Start date
January 17, 2020
Completion date
February 24, 2021
Enrollment
1 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases